APA

Firbas C., Jilma B., Tauber E., Buerger V., Jelovcan S., Lingnau K., Buschle M., Frisch J. & Klade C. S. (20061003). Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. : Vaccine.

Chicago

Firbas Christa, Jilma Bernd, Tauber Erich, Buerger Vera, Jelovcan Sandra, Lingnau Karen, Buschle Michael, Frisch Jürgen and Klade Christoph S. 20061003. Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. : Vaccine.

Harvard

Firbas C., Jilma B., Tauber E., Buerger V., Jelovcan S., Lingnau K., Buschle M., Frisch J. and Klade C. S. (20061003). Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. : Vaccine.

MLA

Firbas Christa, Jilma Bernd, Tauber Erich, Buerger Vera, Jelovcan Sandra, Lingnau Karen, Buschle Michael, Frisch Jürgen and Klade Christoph S. Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. : Vaccine. 20061003.